(VTGN) VistaGen Therapeutics - Performance -30.2% in 12m
VTGN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-84.66%
#155 in Peer-Group
Rel. Strength
15.95%
#6452 in Stock-Universe
Total Return 12m
-30.17%
#100 in Peer-Group
Total Return 5y
-85.66%
#105 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.94 USD |
| 52 Week Low | 1.96 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 92.31 |
| Buy/Sell Signal +-5 | -1.22 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VTGN (-30.2%) vs XBI (-7.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
4.78% | 72% | 82.5% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.68% | -8.84% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.37% | -3.61% | 40.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.33% | 33.2% | -0.68% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
8.13% | -8.29% | 7.01% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
14.7% | 39.8% | -2.94% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.29% | 55.9% | -6.21% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.06% | 28.4% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: VTGN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VTGN
| Total Return (including Dividends) | VTGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 1.67% | 3.64% | 4.08% |
| 3 Months | 18.54% | 23.43% | 19.65% |
| 12 Months | -30.17% | -7.41% | 12.88% |
| 5 Years | -85.66% | -20.74% | 113.48% |
| Trend Score (consistency of price movement) | VTGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -2.9% | 30.3% | 86.9% |
| 3 Months | 2.9% | 79.4% | 97.2% |
| 12 Months | -88.3% | -87.3% | 46% |
| 5 Years | -83.3% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th55.00 | -1.90% | -2.31% |
| 3 Month | %th38.00 | -3.96% | -0.93% |
| 12 Month | %th50.00 | -24.59% | -38.14% |
| 5 Years | %th47.50 | -81.91% | -93.28% |
FAQs
Does VistaGen Therapeutics (VTGN) outperform the market?
No,
over the last 12 months VTGN made -30.17%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.41%.
Over the last 3 months VTGN made 18.54%, while XBI made 23.43%.
Performance Comparison VTGN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VTGN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 21.4% | -2.4% | -26.6% | -43% |
| US NASDAQ 100 | QQQ | 21.6% | -2.4% | -28% | -41% |
| German DAX 40 | DAX | 19.3% | -0.2% | -38.7% | -62% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 20% | -3.6% | -31% | -51% |
| Hongkong Hang Seng | HSI | 22.6% | -0.8% | -46.9% | -67% |
| India NIFTY 50 | INDA | 22.4% | 1.7% | -26.1% | -28% |
| Brasil Bovespa | EWZ | 26.9% | -0.2% | -42.6% | -33% |
VTGN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 22.7% | -0.5% | -30.2% | -53% |
| Consumer Discretionary | XLY | 21.4% | -0.8% | -18.9% | -47% |
| Consumer Staples | XLP | 22.8% | 1.8% | -25.7% | -38% |
| Energy | XLE | 19.6% | -3.5% | -20.2% | -33% |
| Financial | XLF | 22.4% | -1.9% | -30.4% | -58% |
| Health Care | XLV | 20.9% | 0.7% | -16.7% | -25% |
| Industrial | XLI | 20.6% | -3.2% | -33.7% | -56% |
| Materials | XLB | 20.5% | -2.6% | -30% | -37% |
| Real Estate | XLRE | 22% | 2.3% | -26% | -41% |
| Technology | XLK | 21.5% | -5.2% | -30.9% | -39% |
| Utilities | XLU | 20.6% | -1.2% | -29% | -53% |
| Aerospace & Defense | XAR | 21.1% | -4.9% | -44.8% | -79% |
| Biotech | XBI | 17.8% | -2% | -17% | -23% |
| Homebuilder | XHB | 18.1% | -6.7% | -22.3% | -36% |
| Retail | XRT | 21.1% | -1.1% | -21.1% | -41% |
VTGN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 21.2% | -3.62% | -11.7% | -24% |
| Natural Gas | UNG | 24.8% | 9.8% | 1.7% | -25% |
| Gold | GLD | 21.8% | 1.8% | -41.5% | -70% |
| Silver | SLV | 20.8% | 0.1% | -40.4% | -50% |
| Copper | CPER | 12.4% | -11.7% | -47.6% | -53% |
VTGN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 21.5% | 0% | -22.2% | -28% |
| iShares High Yield Corp. Bond | HYG | 21.8% | 0.4% | -23.2% | -40% |